Biotie Therapies Corp.

Two years ago, Acorda Therapeutics Inc. CEO Ron Cohen was sitting in the witness chair in the US District Court for the District of Delaware, trying to convince US District Judge Leonard Stark that

Two years ago, Acorda Therapeutics Inc. CEO Ron Cohen was sitting in the witness chair in the US District Court for the District of Delaware, trying to convince US District Judge Leonard Stark that

Five big investments in health care and life science funds since the end of October delivered more than $1bn in new financing for companies developing biopharmaceuticals and related technology. The ne

Even if Acorda Therapeutics Inc. 's A2a receptor inhibitor tozadenant gets past the treatment-related deaths seen in Parkinson's disease trials and winds up getting approved, it still may struggle